Understanding Covid-19 lethality and its variation from country to country is essential for supporting governments in the choice of appropriate strategies. Adopting correct indicators to monitor the lethality of the infection in the course of the outbreak is a crucial issue. This works highlights how far the case fatality ratio, as calculated day by day in the course of the outbreak, is a misleading indicator for estimating the fatality rate, even if our attention is only restricted to the subset of confirmed cases. We prove that the final case fatality ratio for several major European countries is bound to largely exceed 10%. The difference in the case fatality ratio values between Italy and other major European countries considered in this work (except for the case of Germany), often interpreted in terms of peculiarities of the Italian population or health system, is to be mostly attributed to the more advanced stage of the Italian epidemic.
Introduction
Different countries are adopting different strategies to face the Covid-10 pandemic 1 . Monitoring Covid-19 lethality and its variation from country to country is essential for supporting governments in selecting the appropriate decisions. The adoption of correct indicators to monitor the lethality of the infection in the course of the outbreak is therefore a crucial issue. 2, 3 The following terms are used in this work: the infection fatality ratio, IFR, indicates the ratio between the total deaths and total infected patients within a given population; the final case fatality ratio, In order to show how deceptive, though common, is the approach of ignoring the error (b), thus directly estimating Fig. 3 . The curves have been shifted on the time axis for better alignment, based on the evolution of the death curve in the country. The earliest days are omitted because largely affected, for most nations, by insufficient testing. The plot confirms the claims based on the simulation: all the curves show a clear growing trend and a behaviour which is reminiscent of the dark blue curve in Fig. 2 . Both IT and DE presently show a   CFR t value exceeding by over five times the ones of the early stage of the epidemic, while a slightly lower but comparable factor applies to UK, ES, NL and FR. The curves for IT, ES, UK and NL seem to be all bound to converge towards comparable final CF R values, in spite of the large present differences. The behaviour of the US curve is so far very difficult to interpret and certainly affected by large State-to-State inhomogeneities, also in terms of starting date of the outbreak. 
